Elli Kaplan is co-founder and CEO of Neurotrack, a health company facilitating earlier cognitive assessment and therapy for cognitive diseases like Alzheimer’s. Neurotrack has incorporated leading scientific research through a digital cognitive assessment test and a lifestyle program designed to prevent cognitive decline and improve overall cognitive health.

Elli has two decades of experience in the public and private sectors, including positions at the White House, the State and Treasury Departments, and the United Nations Development Program. She also held positions with AIG, Goldman Sachs and multiple startups, and has an M.B.A. from Harvard.